The PCI Center

Filter Your Results

Alvimedica’s 2-mm Cre8 Evo DES Receives CE Mark Approval

February 4, 2019 -- Alvimedica announced European CE Mark approval of its 2-mm Cre8 EVO drug-eluting stent, further enlarging the company's polymer-free, amphilimus-eluting st…

Impella Connect Cloud-Based Monitoring Platform Approved in Europe

January 31, 2019 -- Abiomed announced it has received European CE Mark approval for its Impella Connect, a cloud-based technology that enables secure, real-time, remote viewin…

Shockwave Begins DISRUPT CAD III Pivotal Trial of Coronary Intravascular Lithotripsy

January 14, 2019 -- Shockwave Medical, Inc. announced that it has initiated the pivotal DISRUPT CAD III clinical trial, its FDA investigational device exemption (IDE) study ev…

Railway™: The Future of Radial Access

Kintur Sanghvi, MD, FACC, FSCAI

November/December 2018—An inventor’s perspective on using the Railway™ device to overcome even the most challenging cases.

CASE REPORT: Railway™ Sheathless Guide System

Srini Potluri, MD

November/December 2018—The initial experience using novel sheathless technology to facilitate optimal radial access.

Overcoming Radial Access Challenges

With John C. Wang, MD, MSc; and Kevin J. Croce, MD, PhD

November/December 2018—Case reports with commentary describing techniques for managing tortuosity during PCI for coronary artery disease.

Transitioning to a Radial-First Approach

Cheryl Lunnen

November/December 2018—How far are you willing to take radial access?

Real-World Results With the EluNIR™ Coronary Stent System

With Mehran Moussavian, DO; Joseph A.R. Cardenas, MD, FACC; Mohammad M. Ansari, MD; and Pakpoom Tantrachoti, MD

November/December 2018—Case reports illustrating the utility of the EluNIR™ coronary stent system in challenging scenarios.

...

152

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

Selection of Hemodynamic Support: An Approach for Coronary Interventions in Shock and High-Risk PCI

The role of hemodynamic support devices in emergent cardiogenic shock and elective high-risk percutaneous coronary intervention.

By Sahil Khera, MD, MPH; and Srihari S. Naidu, MD

The National Cardiogenic Shock Initiative

Dr. William W. O’Neill shares his experience with launching this initiative at both the regional and national levels.

The PCI Center

Filter Your Results

News

Alvimedica’s 2-mm Cre8 Evo DES Receives CE Mark Approval

Impella Connect Cloud-Based Monitoring Platform Approved in Europe

Shockwave Begins DISRUPT CAD III Pivotal Trial of Coronary Intravascular Lithotripsy

Railway™: The Future of Radial Access

Kintur Sanghvi, MD, FACC, FSCAI

CASE REPORT: Railway™ Sheathless Guide System

Srini Potluri, MD

Overcoming Radial Access Challenges

With John C. Wang, MD, MSc; and Kevin J. Croce, MD, PhD

Transitioning to a Radial-First Approach

Cheryl Lunnen

Real-World Results With the EluNIR™ Coronary Stent System

With Mehran Moussavian, DO; Joseph A.R. Cardenas, MD, FACC; Mohammad M. Ansari, MD; and Pakpoom Tantrachoti, MD

Featured Video

Top 5 In PCI Center

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

Selection of Hemodynamic Support: An Approach for Coronary Interventions in Shock and High-Risk PCI

By Sahil Khera, MD, MPH; and Srihari S. Naidu, MD

The National Cardiogenic Shock Initiative

With William W. O’Neill, MD, MSCAI; and Michael J. Lim, MD

Two-Year BIONICS Data Presented for Medinol's EluNIR Stent

Lepu Medical's NeoVas Bioresorbable Scaffold Shown to Be Noninferior to Metallic Drug-Eluting Stents

Centers

Contact Info

Other Resources

About Cardiac Interventions Today